Global protein labeling market would reach $5,350 million by 2022 from $2,002 million in 2015, growing at a CAGR of 14.9% during the forecast period. Reagents segment is estimated to dominate the global protein labeling market throughout the analysis period. Majority of the global protein labeling market share was captured by U.S. in 2015.
The emerging trends in protein labeling such as emergence of more specific labels with higher affinity and binding properties, bioorthogonal labeling, and customized label designing would fuel the global protein labeling market growth. Such advanced labels help in better marking, identification, separation, and quantification of proteins.
Amongst the labeling methods, the in vivo labeling segment dominates the market with more than half of the global protein labeling market in 2015. This is mainly attributed to ease of availability of products and reagents and the stability of this method. However, bioorthogonal labeling segment is expected to be the fastest growing segment. This is attributed to the fact that this method of proteins labeling can be carried out in living cells without hindering the biochemical functioning of the cell.
Based on geography, North America generated the highest revenue in 2015, accounting for the majority of the share of global protein labeling market, due to various technological advancements, rise in R&D investments, and surge in demand for protein labeling products. Furthermore, North America is estimated to continue to dominate the world market, owing to rise in technological innovations and significant rise in funding. The Asia-Pacific region is expected to be the fastest growing segment, owing to the increased demands of emerging economies such as Japan and China and rise in healthcare expenditure.
Key findings of the Protein Labeling Market Study:
- Nanoparticle labeling segment is estimated to exhibit a CAGR of 17.4%, among in vitro labeling.
- Fluorescence Microscopy segment will exhibit a CAGR of 16.1% in LAMEA region.
- Research laboratories segment holds two-thirds of the share in the end-user protein labeling market.
- Photoreactive labeling segment for in vivo protein labeling is projected to be the fastest growing segment from 2016 to 2022.
- Mexico was the smallest economy market in 2015, and is projected to grow at a CAGR of 15.7% through 2022.
The key developmental strategies adopted by leading market players are product launches, collaborations, and partnerships. The prominent market players profiled in the report include General Electric Company, Kaneka Corporation, LI-COR, Inc., Merck & Co., Inc., New England Biolabs, Inc., PerkinElmer, Inc., Promega Corporation, F. Hoffmann-LA Roche AG, Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc.
0 Comments